|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Inverness Medical Innovations, Inc. (AMEX: IMA), a leading manufacturer of rapid diagnostic products for the consumer and professional markets, with a focus on women's health, cardiology and infectious disease. |
|---|---|
| Transferring Party | Instant Technologies, Inc., a leading supplier of on-site rapid test devices that include drug and alcohol testing, women's health and clinical diagnostics. |
| Sector | Diagnostics |
| Date | March 14, 2007 |
| Analysis For $43.7m, Inverness buys 75% of Instant Technologies, the largest single distributor for Inverness' drugs of abuse testing products. There are provisions for the buyout of the remaining 25%. Instant Technologies' revenues are $23.0m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |